eMedicine Specialties > Neurology > Critical Care Neurology

Epidural Hematoma: Treatment & Medication

Author: David S Liebeskind, MD, Associate Professor of Neurology, Program Director, Vascular Neurology Residency Program, University of California at Los Angeles; Neurology Director, Stroke Imaging Program, Co-Medical Director, Cerebral Blood Flow Laboratory, Associate Neurology Director, UCLA Stroke Center
Contributor Information and Disclosures

Updated: Mar 10, 2009

Treatment

Medical Care

Initial resuscitation efforts should include assessment and stabilization of airway patency, breathing, and circulation. A thorough trauma evaluation is mandatory, including inspection for skull fractures and appreciation of the force and location of impact. Immobilization of the spine should be followed by emergent transfer of the patient to the nearest level I trauma center supported with neurosurgical consultation.

  • Triage and initial management of a patient with epidural hematoma may be tailored to the degree of neurological impairment at presentation. Alert patients may be evaluated with a CT scan following a brief neurologic examination.
  • A patient with a small epidural hematoma may be treated conservatively, though close observation is advised, as delayed, yet sudden, neurological deterioration may occur.
  • Trauma patients may require diagnostic peritoneal lavage and radiographs of the chest, pelvis, and cervical spine.
  • While neurosurgical consultation is requested, administer intravenous fluids to maintain euvolemia and to provide adequate cerebral perfusion pressure.
  • Patients with elevated intracranial pressure may be treated with osmotic diuretics and hyperventilation, with elevation of the head of the bed at an angle of 30 degrees. Patients who are intubated may be hyperventilated with intermittent mandatory ventilation at a rate of 16-20 breaths per minute and tidal volume of 10-12 mL/kg. A carbon dioxide partial pressure of 28-32 mm Hg is ideal, as severe hypocapnia (<25 mm Hg) may induce cerebral vasoconstriction and ischemia.
  • Coagulopathy or persistent bleeding may require administration of vitamin K, protamine sulfate, fresh frozen plasma, platelet transfusions, or clotting factor concentrates.

Surgical Care

Although several recent reports have described successful conservative management of epidural hematoma, surgical evacuation constitutes definitive treatment of this condition. Craniotomy or laminectomy is followed by evacuation of the hematoma, coagulation of bleeding sites, and inspection of the dura. The dura is then tented to the bone and, occasionally, epidural drains are employed for as long as 24 hours.

  • Minimally invasive surgical procedures, including the use of burr holes and negative pressure drainage, may be used in selected cases.
  • Novel therapeutic approaches
    • Endovascular embolization to minimize bleeding during the acute stage
    • Thrombolytic evacuation using closed suction drain
CT scanning performed before and after surgical e...

CT scanning performed before and after surgical evacuation of an intracranial epidural hematoma.

CT scanning performed before and after surgical e...

CT scanning performed before and after surgical evacuation of an intracranial epidural hematoma.


Consultations

  • Neurosurgeon (for potential emergent evacuation of the hematoma)
  • Neurologist
  • Rehabilitation specialist

Diet

The hypermetabolic and catabolic phenomena associated with severe head injury necessitate caloric supplementation. Initiate enteral feedings as soon as possible.

Activity

Patients who are treated conservatively should undergo close observation and should avoid strenuous activity. Inpatients should remain on bedrest during the initial phase; this can be followed by a progressive increase in activity.

Medication

Osmotic diuretics, such as mannitol or hypertonic saline, may be used to diminish intracranial pressure. As hyperthermia may exacerbate neurological injury, acetaminophen may be given to reduce fevers. Anticonvulsants are used routinely to avoid seizures that may be induced by cortical damage. Patients with spinal epidural hematoma may require high-dose methylprednisolone when spinal cord compression is involved. Immobilized patients may require heparin for prevention of venous thrombosis, whereas vitamin K and protamine may be administered to restore normal coagulation parameters. Antacids are used to prevent gastric ulcers associated with traumatic brain injury and spinal cord damage.

Osmotic diuretics

These agents reverse the pressure gradient across the blood-brain barrier, reducing intracranial pressure.


Mannitol (Osmitrol, Resectisol)

Reduces cerebral edema by osmotic forces and decreases blood viscosity, resulting in reflex vasoconstriction and lowering of intracranial pressure.

Adult

0.75-1 g/kg IV, followed by 0.25-0.5 g/kg IV q3-5h to maintain serum hyperosmolarity (approximately 320 mOsm/L)

Pediatric

Not established; dose is dependent on weight, clinical condition, and laboratory results

May decrease serum lithium levels

Documented hypersensitivity; anuria; severe pulmonary congestion or frank pulmonary edema; active intracranial bleeding; severe dehydration; progressive renal or cardiac failure

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Perform periodic clinical evaluation and laboratory assessment to monitor changes in serum osmolarity, fluids, and electrolytes; persistently elevated serum osmolarity may result in rebound intracranial hypertension
Caution in renal dysfunction, hypervolemia, urinary tract obstruction, or cardiovascular instability

Antipyretic agents

These agents are helpful in relieving the fever associated with the condition.


Acetaminophen (Tylenol, Feverall, Aspirin Free Anacin)

Reduces fever and maintains normothermia. DOC for pain in patients with documented hypersensitivity to aspirin or NSAIDs, with upper GI disease, or who are taking oral anticoagulants.

Adult

650 mg PO/PR q4-6h; not to exceed maximum daily dosage of 4 g

Pediatric

<12 years: 10-15 mg/kg/dose PO/PR q4-6h prn; not to exceed 2.6 g/d
>12 years: 325-650 mg PO/PR q4h; not to exceed 5 doses (2.6 g) in 24 h

Rifampin can reduce analgesic effects; barbiturates, carbamazepine, hydantoins, and isoniazid may increase hepatotoxicity

Documented hypersensitivity; known G-6-P deficiency; hepatic dysfunction

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Hepatotoxicity possible in patients with chronic alcoholism following various dose levels; severe or recurrent pain or high or continued fever may indicate serious illness; acetaminophen contained in many OTC products and combined use with these products may result in cumulative doses exceeding recommended maximum dose

Anticonvulsants

These agents reduce frequency of early posttraumatic seizures from 14% to 4%, but they do not prevent later seizures. If seizures are not experienced for 7-10 d, the drug may be discontinued.


Fosphenytoin (Cerebyx)

Converted to phenytoin, which modulates neuronal voltage-dependent sodium channels.

Adult

15-20 mg/kg IV loading dose, followed by 300 mg IV q24h

Pediatric

Not established; weight-adjusted dosage similar to that in adults

Amiodarone, benzodiazepines, chloramphenicol, cimetidine, fluconazole, isoniazid, metronidazole, miconazole, phenylbutazone, succinimides, sulfonamides, omeprazole, phenacemide, disulfiram, ethanol (acute ingestion), trimethoprim, and valproic acid may increase toxicity;
Barbiturates, diazoxide, ethanol (chronic ingestion), rifampin, antacids, charcoal, carbamazepine, theophylline, and sucralfate decrease effects
Decreases effects of acetaminophen, corticosteroids, dicumarol, disopyramide, doxycycline, estrogens, haloperidol, amiodarone, carbamazepine, cardiac glycosides, quinidine, theophylline, methadone, metyrapone, mexiletine, oral contraceptives, and valproic acid

Documented hypersensitivity; sinus bradycardia; sinoatrial and third-degree AV block; Adams-Stokes syndrome

Pregnancy

D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus

Precautions

Avoid rapid administration to reduce risks of hypotension and cardiac arrhythmias; monitor for blood dyscrasias with serial blood tests; discontinue use if skin rash appears and do not resume use if rash is exfoliative, bullous, or purpuric; use caution in patients with acute intermittent porphyria, diabetes, or hepatic dysfunction

Corticosteroids

Anti-inflammatory properties mitigate tissue damage in spinal cord compression.


Methylprednisolone (Adlone, Medrol, Solu-Medrol)

Reduces injury associated with spinal cord compression. Decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reversing increased capillary permeability.

Adult

30 mg/kg IV bolus, followed by 4 mg/kg IV infusion over next 23 h

Pediatric

Administer as in adults

Inhibits metabolism of cyclosporine; inducers of hepatic enzymes (eg, phenobarbital, phenytoin, rifampin) increase clearance; troleandomycin and ketoconazole inhibit metabolism; variable interaction with aspirin and oral anticoagulants

Documented hypersensitivity; systemic fungal infection

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Caution in ulcerative colitis, peptic ulcer disease, renal insufficiency, hypertension, osteoporosis, myasthenia gravis, hypothyroidism, cirrhosis, and ocular herpes simplex; reductions in dosage should be gradual; psychic derangements may occur

Antidotes

These agents reverse some coagulopathies or bleeding diatheses.


Phytonadione; vitamin K (AquaMEPHYTON, Konakion, Mephyton)

Promotes hepatic synthesis of clotting factors that inhibit warfarin effects.

Adult

2.5-10 mg IM/SC; repeat administration q6-8h until PT normalized

Pediatric

Not established; suggested dose is as in adults

Antagonizes effects of warfarin sodium and dicumarol

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Ineffective in hereditary hypoprothrombinemia


Protamine sulfate

Neutralizes effects of heparin.

Adult

Dosage adjusted to time interval since discontinuation of IV heparin
Immediately: 1-1.5 mg/100 U heparin
30-60 min from discontinuation of heparin: 0.5-0.75 mg/100 U heparin
>60 min from discontinuation of heparin: 0.25-0.375 mg/100 U heparin
If SC heparin used, give 1-1.5 mg/100 U heparin; not to exceed 50 mg IV over 10 min

Pediatric

Not established; suggested dose is as in adults

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Anticoagulant effects may occur if maximum dose exceeded

Antacids

These agents provide prophylaxis of gastric ulcers.


Famotidine (Pepcid)

Competitively inhibits histamine at H2 receptor of gastric parietal cells, resulting in reduced gastric acid secretion, gastric volume, and hydrogen concentrations. Minimizes development of gastric ulcers.

Adult

20 mg IV/PO bid

Pediatric

Not established; suggested dose is as in adults

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Adjust dosage in patients with renal insufficiency

Anticoagulants

These agents reduce risk of venous complications in immobilized patients.


Heparin

Augments activity of antithrombin III and prevents conversion of fibrinogen to fibrin. Does not actively lyse but is able to inhibit further thrombogenesis. Prevents re-accumulation of clot after spontaneous fibrinolysis. Used for prophylaxis of deep venous thrombosis.

Adult

5000 U SC bid

Pediatric

Weight-adjusted dosage

Antiplatelet agents may exacerbate hemorrhagic risk associated with heparin; digitalis, tetracyclines, nicotine, and antihistamines may interfere with heparin; precipitates may form when used in conjunction with doxorubicin, droperidol, ciprofloxacin, or mitoxantrone

Documented hypersensitivity; subacute bacterial endocarditis; active bleeding; history of heparin-induced thrombocytopenia

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

In neonates, preservative-free heparin recommended to avoid possible toxicity (ie, gasping syndrome) by benzyl alcohol, which is used as preservative; caution in severe hypotension and shock; monitor for bleeding in peptic ulcer disease, menstruation, increased capillary permeability, and when giving IM injections; discontinue use if thrombocytopenia develops

More on Epidural Hematoma

Overview: Epidural Hematoma
Differential Diagnoses & Workup: Epidural Hematoma
Treatment & Medication: Epidural Hematoma
Follow-up: Epidural Hematoma
Multimedia: Epidural Hematoma
References

References

  1. Huisman TA, Tschirch FT. Epidural hematoma in children: Do cranial sutures act as a barrier?. J Neuroradiol. Aug 11 2008;[Medline].

  2. Gouveia LO, Castanho P, Ferreira JJ, Guedes MM, Falcao F, e Melo TP. Chiropractic manipulation: reasons for concern?. Clin Neurol Neurosurg. Dec 2007;109(10):922-5. [Medline].

  3. Fujiwara H, Oki K, Momoshima S. PROPELLER diffusion-weighted magnetic resonance imaging of acute spinal epidural hematoma. Acta Radiol. Aug 2005;46(5):539-42. [Medline].

  4. Liu JT, Tyan YS, Lee YK. Emergency management of epidural haematoma through burr hole evacuation and drainage. A preliminary report. Acta Neurochir (Wien). Mar 2006;148(3):313-7. [Medline].

  5. Chang FC, Lirng JF, Luo CB. Evaluation of clinical and MR findings for the prognosis of spinal epidural haematomas. Clin Radiol. Jul 2005;60(7):762-70. [Medline].

  6. Arrese I, Lobato RD, Gomez PA. Hyperacute epidural haematoma isodense with the brain on computed tomography. Acta Neurochir (Wien). Feb 2004;146(2):193-4. [Medline].

  7. Awad JN, Kebaish KM, Donigan J. Analysis of the risk factors for the development of post-operative spinal epidural haematoma. J Bone Joint Surg Br. Sep 2005;87(9):1248-52. [Medline].

  8. Bejjani GK, Donahue DJ, Rusin J, Broemeling LD. Radiological and clinical criteria for the management of epidural hematomas in children. Pediatr Neurosurg. Dec 1996;25(6):302-8. [Medline].

  9. Berry C, Sandberg DI, Hoh DJ, Krieger MD, McComb JG. Use of cranial fixation pins in pediatric neurosurgery. Neurosurgery. Apr 2008;62(4):913-8; discussion 918-9. [Medline].

  10. Bezircioglu H, Ersahin Y, Demircivi F, et al. Nonoperative treatment of acute extradural hematomas: analysis of 80 cases. J Trauma. Oct 1996;41(4):696-8. [Medline].

  11. Borovich B, Braun J, Guilburd JN, et al. Delayed onset of traumatic extradural hematoma. J Neurosurg. Jul 1985;63(1):30-4. [Medline].

  12. Bozbuga M, Izgi N, Polat G, Gurel I. Posterior fossa epidural hematomas: observations on a series of 73 cases. Neurosurg Rev. 1999;22(1):34-40. [Medline].

  13. Cohen JE, Montero A, Israel ZH. Prognosis and clinical relevance of anisocoria-craniotomy latency for epidural hematoma in comatose patients. J Trauma. Jul 1996;41(1):120-2. [Medline].

  14. de Andrade AF, Figueiredo EG, Caldas JG, Paiva WS, De Amorim RL, Puglia P, et al. Intracranial vascular lesions associated with small epidural hematomas. Neurosurgery. Feb 2008;62(2):416-20; discussion 420-1. [Medline].

  15. De Souza M, Moncure M, Lansford T, Albaugh G, Tarnoff M, Goodman M, et al. Nonoperative management of epidural hematomas and subdural hematomas: is it safe in lesions measuring one centimeter or less?. J Trauma. Aug 2007;63(2):370-2. [Medline].

  16. Durand P, Adamson GJ. On-the-field management of athletic head injuries. J Am Acad Orthop Surg. May-Jun 2004;12(3):191-5. [Medline].

  17. Fukui MB, Swarnkar AS, Williams RL. Acute spontaneous spinal epidural hematomas. Am J Neuroradiol. Aug 1999;20(7):1365-72. [Medline].

  18. Guay J. Estimating the incidence of epidural hematoma - is there enough information?. Can J Anaesth. May 2004;51(5):514-5. [Medline].

  19. Heyman R, Heckly A, Magagi J. Intracranial epidural hematoma in newborn infants: clinical study of 15 cases. Neurosurgery. Nov 2005;57(5):924-9; discussion 924-9. [Medline].

  20. Holtas S, Heiling M, Lonntoft M. Spontaneous spinal epidural hematoma: findings at MR imaging and clinical correlation. Radiology. May 1996;199(2):409-13. [Medline].

  21. Ibanez J, Arikan F, Pedraza S. Reliability of clinical guidelines in the detection of patients at risk following mild head injury: results of a prospective study. J Neurosurg. May 2004;100(5):825-34. [Medline].

  22. Knopman J, Tsiouris AJ, Souweidane MM. Atraumatic epidural hematoma secondary to a venous sinus thrombosis: a novel finding. J Neurosurg Pediatrics. Dec 2008;2(6):416-9. [Medline].

  23. Koch BL, Moosbrugger EA, Egelhoff JC. Symptomatic spinal epidural collections after lumbar puncture in children. AJNR Am J Neuroradiol. Oct 2007;28(9):1811-6. [Medline].

  24. Koenig MA, Bryan M, Lewin JL 3rd, Mirski MA, Geocadin RG, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. Neurology. Mar 25 2008;70(13):1023-9. [Medline].

  25. Layton KF, Kallmes DF, Horlocker TT. Recommendations for anticoagulated patients undergoing image-guided spinal procedures. AJNR Am J Neuroradiol. Mar 2006;27(3):468-70. [Medline].

  26. Lee EJ, Hung YC, Wang LC, et al. Factors influencing the functional outcome of patients with acute epidural hematomas: analysis of 200 patients undergoing surgery. J Trauma. Nov 1998;45(5):946-52. [Medline].

  27. Liu W, Ma L, Wen L, Shen F, Sheng H, Zhou B, et al. Drilling skull plus injection of urokinase in the treatment of epidural haematoma: a preliminary study. Brain Inj. Feb 2008;22(2):199-204. [Medline].

  28. McClelland S 3rd, Won EK, Lam CH. Utilization of recombinant activated factor VII for intracranial hematoma evacuation in coagulopathic nonhemophilic neurosurgical patients with normal international normalized ratios. Neurocrit Care. 2007;7(2):136-9. [Medline].

  29. Miller DJ, Steinmetz M, McCutcheon IE. Vertex epidural hematoma: surgical versus conservative management: two case reports and review of the literature. Neurosurgery. Sep 1999;45(3):621-4; discussion 624-5. [Medline].

  30. Muench MV, Zheng M, Bilica PM, Canterino JC. Prenatal diagnosis of a fetal epidural hematoma using 2- and 3-dimensional sonography and magnetic resonance imaging. J Ultrasound Med. Sep 2008;27(9):1369-73. [Medline].

  31. Narayan RK, Wilberger JE Jr, Povlishock JT, eds. Neurotrauma. First ed. New York: McGraw Hill; 1996.

  32. Pahapill PA, Lownie SP. Conservative treatment of acute spontaneous spinal epidural hematoma. Can J Neurol Sci. May 1998;25(2):159-63. [Medline].

  33. Park J, Kim GJ, Hwang SK. Thrombolytic evacuation of post-craniotomy epidural haematomas using closed suction drains: a pilot study. Acta Neurochir (Wien). Apr 2008;150(4):359-66; discussion 366. [Medline].

  34. Rivas JJ, Lobato RD, Sarabia R, et al. Extradural hematoma: analysis of factors influencing the courses of 161 patients. Neurosurgery. Jul 1988;23(1):44-51. [Medline].

  35. Ruppen W, Derry S, McQuay HJ, Moore RA. Incidence of epidural haematoma and neurological injury in cardiovascular patients with epidural analgesia/anaesthesia: systematic review and meta-analysis. BMC Anesthesiol. Sep 12 2006;6:10. [Medline].

  36. Servadei F. Prognostic factors in severely head injured adult patients with epidural haematoma's. Acta Neurochir (Wien). 1997;139(4):273-8. [Medline].

  37. Sokolowski MJ, Garvey TA, Perl J 2nd, Sokolowski MS, Cho W, Mehbod AA, et al. Prospective study of postoperative lumbar epidural hematoma: incidence and risk factors. Spine. Jan 1 2008;33(1):108-13. [Medline].

  38. Suzuki S, Endo M, Kurata A. Efficacy of endovascular surgery for the treatment of acute epidural hematomas. AJNR Am J Neuroradiol. Aug 2004;25(7):1177-80. [Medline].

  39. Tallon JM, Ackroyd-Stolarz S, Karim SA, Clarke DB. The epidemiology of surgically treated acute subdural and epidural hematomas in patients with head injuries: a population-based study. Can J Surg. Oct 2008;51(5):339-45. [Medline].

  40. Vitali AM, Steinbok P. Depressed skull fracture and epidural hematoma from head fixation with pins for craniotomy in children. Childs Nerv Syst. Aug 2008;24(8):917-23; discussion 925. [Medline].

  41. Wester K. Decompressive surgery for "pure" epidural hematomas: does neurosurgical expertise improve the outcome?. Neurosurgery. Mar 1999;44(3):495-500; discussion 500-2. [Medline].

  42. Whedon JM. Lumbar epidural hematoma after chiropractic manipulation for lower-back pain: case report. Neurosurgery. Aug 2008;63(2):E376; author reply E376. [Medline].

  43. Wysowski DK, Talarico L, Bacsanyi J, Botstein P. Spinal and epidural hematoma and low-molecular-weight heparin. N Engl J Med. Jun 11 1998;338(24):1774-5. [Medline].

  44. Yilmazlar S, Kocaeli H, Dogan S. Traumatic epidural haematomas of nonarterial origin: analysis of 30 consecutive cases. Acta Neurochir (Wien). Dec 2005;147(12):1241-8; discussion 1248. [Medline].

  45. Yuh EL, Gean AD, Manley GT, Callen AL, Wintermark M. Computer-aided assessment of head computed tomography (CT) studies in patients with suspected traumatic brain injury. J Neurotrauma. Oct 2008;25(10):1163-72. [Medline].

Further Reading

Keywords

epidural hemorrhage, extradural hematoma, extradural hemorrhage, cerebral epidural hematoma, spinal epidural hematoma, EDH, SEDH, head injury, intracranial epidural hematoma

Contributor Information and Disclosures

Author

David S Liebeskind, MD, Associate Professor of Neurology, Program Director, Vascular Neurology Residency Program, University of California at Los Angeles; Neurology Director, Stroke Imaging Program, Co-Medical Director, Cerebral Blood Flow Laboratory, Associate Neurology Director, UCLA Stroke Center
David S Liebeskind, MD is a member of the following medical societies: American Academy of Neurology, American Heart Association, American Medical Association, American Society of Neuroimaging, American Society of Neuroradiology, National Stroke Association, and Stroke Council of the American Heart Association
Disclosure: Nothing to disclose.

Medical Editor

Edward L Hogan, MD, Professor, Department of Neurology, Medical College of Georgia; Emeritus Professor and Chair, Department of Neurology, Medical University of South Carolina
Edward L Hogan, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, American Neurological Association, American Society for Biochemistry and Molecular Biology, Phi Beta Kappa, Sigma Xi, Society for Neuroscience, and Southern Clinical Neurological Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Howard S Kirshner, MD, Professor of Neurology, Psychiatry and Hearing and Speech Sciences, Vice Chairman, Department of Neurology, Vanderbilt University School of Medicine; Director, Vanderbilt Stroke Center; Program Director, Stroke Service, Vanderbilt Stallworth Rehabilitation Hospital; Consulting Staff, Department of Neurology, Nashville Veterans Affairs Medical Center
Howard S Kirshner, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, American Heart Association, American Medical Association, American Neurological Association, American Society of Neurorehabilitation, National Stroke Association, Phi Beta Kappa, and Tennessee Medical Association
Disclosure: Boehringer Ingelheim Honoraria Speaking and teaching; BMS/Sanofi Honoraria Speaking and teaching; Novartis Honoraria Speaking and teaching

CME Editor

Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital
Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Helmi L Lutsep, MD, Professor, Department of Neurology, Oregon Health and Science University; Associate Director, Oregon Stroke Center
Helmi L Lutsep, MD is a member of the following medical societies: American Academy of Neurology and American Stroke Association
Disclosure: Co-Axia Consulting fee Review panel membership; Talecris Consulting fee Review panel membership; AGA Medical Consulting fee Review panel membership; Boehringer Ingelheim Honoraria Speaking and teaching; Concentric Medical Consulting fee Review panel membership; Abbott Consulting fee Consulting; Sanofi  Consulting

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.